Skip to search formSkip to main contentSkip to account menu

L-364,718

Known as: L 364,718, L 364718, L364,718 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Devazepide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1995
Highly Cited
1995
Agonist-stimulated Cyclic ADP Ribose
We have previously shown that agonist-induced Ca2+ mobilization in intestinal longitudinal muscle is mediated by ryanodine… 
Highly Cited
1995
Highly Cited
1995
Cholecystokinin depolarizes rat thalamic reticular neurons by suppressing a K+ conductance.
1. The thalamic reticular nucleus (nRt) is innervated by cholecystokinin (CCK)-containing neurons and contains CCK binding sites… 
Highly Cited
1993
Highly Cited
1993
Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
Highly Cited
1992
Highly Cited
1992
Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK.
Recent work has suggested a role for an endogenous release of cholecystokinin (CCK) acting at either type A or type B CCK… 
Highly Cited
1991
Highly Cited
1991
CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
To study the interdependence between gastric histamine release and acid secretion, we examined the effects of gastrin-(1-17) [G… 
Highly Cited
1991
Highly Cited
1991
Effects of short-term pancreatic duct obstruction in rats.
Highly Cited
1990
Highly Cited
1990
Gastric emptying in rats: role of afferent neurons and cholecystokinin.
Peptone, acid, and hyperosmolal saline delay gastric emptying in conscious gastric fistula rats. We have now studied the emptying… 
Highly Cited
1989
Highly Cited
1989
Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
The cholecystokinin (CCK) receptor antagonist L 364718 was used to examine the role of CCK in control of food intake. Effects of… 
Highly Cited
1987
Highly Cited
1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
The in vivo pharmacological activity of L-364,718, a new, potent peripheral cholecystokinin (CCK) antagonist, was characterized… 
Highly Cited
1986
Highly Cited
1986
Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
3S(-)-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4- benzodiazepine-3-yl)-1H-indole-2-carboxamide (L-364,718) interacted in a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)